Skip to content

60418ffa00001124 Hypoxanthine catabolic process Mouse

Based on the information I've gathered, I'll now review the GO-CAM model gomodel:60418ffa00001124 - "Hypoxanthine catabolic process (Mouse)".

GO-CAM Review: Hypoxanthine catabolic process (Mouse) - gomodel:60418ffa00001124

Overview

This model represents the hypoxanthine catabolic pathway in mouse, focusing on the conversion of hypoxanthine to allantoin. The model describes the sequence of enzymatic activities involved in this purine degradation pathway, with an emphasis on the role of Xanthine dehydrogenase/oxidase (Xdh) and subsequent enzymes.

Model Assessment

Biological Accuracy and Literature Support

The model accurately represents the hypoxanthine catabolic process as supported by the literature. Specifically:

  1. Pathway flow: The model correctly represents the conversion of hypoxanthine to xanthine, then uric acid, and ultimately to allantoin through several enzymatic steps.

  2. Key enzymes: The model includes all critical enzymes in this pathway:

  3. Xanthine dehydrogenase/oxidase (Xdh) - MGI:MGI:98973
  4. Urate oxidase (Uox) - MGI:MGI:98907
  5. Hydroxyisourate hydrolase (Urah) - MGI:MGI:1916142

  6. 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (Urad) - MGI:MGI:3647519

  7. Enzymatic activities: The model correctly represents multiple enzymatic activities of Xdh, including:

  8. Hypoxanthine dehydrogenase activity (GO:0070674)
  9. Hypoxanthine oxidase activity (GO:0070675)
  10. Xanthine dehydrogenase activity (GO:0004854)

  11. Xanthine oxidase activity (GO:0004855)

  12. Cellular locations: The model appropriately captures the subcellular locations of these activities:

  13. Cytosol (GO:0005829) for the early steps involving Xdh

  14. Peroxisome (GO:0005777) for the later steps involving Uox, Urah, and Urad

  15. Evidence: The model uses appropriate evidence codes and references, including experimental evidence from primary literature.

GO-CAM Structure and Format

  1. Causal relations: The model correctly uses RO:0002413 (provides input for) to connect activities in the pathway, which is appropriate for a metabolic pathway.

  2. Activity connections: The activities are connected in a biologically meaningful way that reflects the flow of this pathway:

  3. Hypoxanthine → Xanthine → Uric acid → 5-hydroxyisourate → OHCU → Allantoin

  4. Molecular functions: Each activity has an appropriate molecular function term assigned.

  5. Process associations: All activities are correctly associated with the biological process "hypoxanthine catabolic process" (GO:0009114).

Strengths of the Model

  1. Comprehensive pathway representation: The model captures the complete pathway from hypoxanthine to allantoin with all intermediary steps.

  2. Multiple forms of Xdh: The model correctly represents the different activities of Xdh (dehydrogenase vs. oxidase), which is biologically important.

  3. Parsimony: Despite representing a complex pathway, the model remains clear and focused.

  4. Strong evidence base: The model is supported by multiple scientific references, including PMID:16462750, which specifically describes the complete uric acid degradation pathway through Urah and Urad.

Suggestions for Improvement

  1. Molecular entities as inputs/outputs: While the model does include allantoin (CHEBI:15676) as an output of the final reaction, it would be beneficial to explicitly represent other chemical intermediates (hypoxanthine, xanthine, uric acid, etc.) as inputs/outputs for each reaction.

  2. Connection to upstream pathways: The model could be enhanced by connecting to upstream purine catabolism pathways that generate hypoxanthine.

  3. Regulation: The model doesn't include regulatory aspects of this pathway, such as the regulation of Xdh activity (which can be modified by proteolysis or oxidation of sulfhydryl groups as noted in the UniProt entry).

Conclusion

The GO-CAM model gomodel:60418ffa00001124 on hypoxanthine catabolic process in mouse is an accurate, well-structured representation of this metabolic pathway. It follows GO-CAM best practices regarding the representation of enzymatic activities and their connections. The model is consistent with the scientific literature, including recent research on the complete uric acid degradation pathway.

The model correctly uses molecular function terms, biological process associations, and cellular component annotations, and it employs appropriate causal relations between activities. It successfully captures the complexity of the Xdh enzyme, which has multiple activities in this pathway.

This model is a good example of a GO-CAM representation of a metabolic pathway, with a clear flow of activities that corresponds to the biological reality.